Novartis’ 41-Year-Old CEO Steers Drug Maker Back to R&D

Vasant Narasimhan, the 41-year-old chief executive at Novartis AG, is vowing data science and digital technologies will revolutionize the company’s drug-development pipeline. All images and written content is property of the listed RSS FEED if you would like more on this story and images please click the listed feed.

Leave a Reply